Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
JadeBio is a contract research organization (CRO) based in La Jolla, California, USA, primarily offering mass spectrometry-based proteomics services. Its customers include pharmaceutical, biotechnology, and academic institutions, with use cases also extending into healthcare, food and agriculture, and industrial biotechnology. Notably, based on the crawled content, it is not a typical SaaS or enterprise software provider, but rather a provider of laboratory testing and outsourced R&D services.
Its core capabilities are built around SRM-MS and multi-stage mass spectrometry platforms, supporting a wide range of sample types including cells, animal and plant tissues, biofluids, environmental samples, and microbial samples. Services include selected reaction monitoring (SRM) targeted quantification, global proteome analysis, unknown protein identification, protein characterization, complete antibody sequencing, ADC characterization, peptide mapping, and immunoprecipitation characterization. The website also highlights detection of post-translational modifications such as phosphorylation and acetylation, as well as relative and absolute protein quantification.
The website does not publish standard packages, a price list, free trials, or an online ordering process. It only states that services are provided at a reasonable cost and with fast turn-around time. Assay development timelines are described as typically taking several days for small protein panels, and up to around 2 months for samples with complex matrices. Overall, it appears to follow a project-based service quotation model, where customers need to contact the company to confirm sample details, target proteins, matrix complexity, and delivery format.
From an enterprise software perspective, JadeBio provides very limited information. There is no visible mention of a cloud platform, self-hosted deployment, APIs, third-party integrations, team collaboration, permission management, audit logs, or data security and compliance certifications. Therefore, if the procurement goal is a LIMS, ELN, laboratory data management system, or bioinformatics analysis SaaS, it is not a good fit. If the goal is outsourced high-sensitivity proteomics experimental services, however, it is highly relevant professionally.
Its strengths are a clear technical focus and well-defined application scenarios. It is particularly suitable for biomarker discovery and validation, companion diagnostics development, clinical trial monitoring, antibody/ADC characterization, food allergen or GMO protein detection, and fermentation process optimization. Its weaknesses are limited commercial transparency, with a lack of detail on pricing, qualifications, data compliance, cross-border sample handling procedures, and service SLAs.
China access is not covered in the main content, and payment methods are not specified. Chinese customers should additionally evaluate website connectivity, cross-border sample shipping, customs and biological sample compliance, USD payments, and time-zone differences in communication. If local delivery is more important, domestic proteomics CROs may be better comparisons. If software-based management is the priority, customers should instead consider LIMS, ELN, or research data platforms.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on jadebio.com official site.
jadebio.com is an Unknown Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach jadebio.com directly.